Axa’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,602,225
| Closed | -$178M | – | 475 |
|
|
2025
Q2 | $178M | Sell |
1,602,225
-2,264
| -0.1% | -$241K | 0.51% | 34 |
|
|
2025
Q1 | $180M | Sell |
1,604,489
-195,568
| -11% | -$20.2M | 0.59% | 31 |
|
|
2024
Q4 | $166M | Buy |
1,800,057
+201,769
| +13% | +$18.2M | 0.51% | 40 |
|
|
2024
Q3 | $134M | Sell |
1,598,288
-147,593
| -8% | -$11.3M | 0.4% | 52 |
|
|
2024
Q2 | $120M | Sell |
1,745,881
-193,526
| -10% | -$12.9M | 0.36% | 57 |
|
|
2024
Q1 | $142M | Buy |
1,939,407
+127,661
| +7% | +$9.82M | 0.43% | 50 |
|
|
2023
Q4 | $147M | Buy |
1,811,746
+64,985
| +4% | +$5.06M | 0.47% | 43 |
|
|
2023
Q3 | $131M | Buy |
1,746,761
+85,819
| +5% | +$6.6M | 0.46% | 45 |
|
|
2023
Q2 | $128M | Sell |
1,660,942
-180,360
| -10% | -$14.4M | 0.43% | 49 |
|
|
2023
Q1 | $153M | Buy |
1,841,302
+660,135
| +56% | +$54.7M | 0.53% | 33 |
|
|
2022
Q4 | $101M | Sell |
1,181,167
-297,313
| -20% | -$23.5M | 0.37% | 59 |
|
|
2022
Q3 | $91.2M | Sell |
1,478,480
-366,793
| -20% | -$23.1M | 0.36% | 60 |
|
|
2022
Q2 | $114M | Sell |
1,845,273
-163,453
| -8% | -$10.1M | 0.42% | 52 |
|
|
2022
Q1 | $119M | Sell |
2,008,726
-45,795
| -2% | -$2.93M | 0.34% | 65 |
|
|
2021
Q4 | $149M | Buy |
2,054,521
+168,312
| +9% | +$11.6M | 0.38% | 59 |
|
|
2021
Q3 | $132M | Buy |
1,886,209
+492,818
| +35% | +$34.6M | 0.37% | 58 |
|
|
2021
Q2 | $95.9M | Buy |
1,393,391
+416,188
| +43% | +$27.8M | 0.27% | 83 |
|
|
2021
Q1 | $63.2M | Sell |
977,203
-64,943
| -6% | -$4.19M | 0.19% | 126 |
|
|
2020
Q4 | $60.7M | Sell |
1,042,146
-3,229
| -0.3% | -$195K | 0.19% | 128 |
|
|
2020
Q3 | $66.1M | Sell |
1,045,375
-214,033
| -17% | -$14.8M | 0.24% | 102 |
|
|
2020
Q2 | $96.9M | Sell |
1,259,408
-13,928
| -1% | -$1.07M | 0.38% | 54 |
|
|
2020
Q1 | $95.2M | Sell |
1,273,336
-152,844
| -11% | -$10.6M | 0.48% | 42 |
|
|
2019
Q4 | $92.7M | Sell |
1,426,180
-200,196
| -12% | -$13M | 0.38% | 55 |
|
|
2019
Q3 | $103M | Sell |
1,626,376
-79,561
| -5% | -$5.2M | 0.41% | 50 |
|
|
2019
Q2 | $115M | Buy |
1,705,937
+47,922
| +3% | +$3.15M | 0.45% | 42 |
|
|
2019
Q1 | $108M | Buy |
1,658,015
+851,198
| +106% | +$56.6M | 0.42% | 44 |
|
|
2018
Q4 | $50.5M | Sell |
806,817
-80,241
| -9% | -$5.61M | 0.22% | 128 |
|
|
2018
Q3 | $68.5M | Buy |
887,058
+100,458
| +13% | +$7.59M | 0.25% | 109 |
|
|
2018
Q2 | $55.7M | Sell |
786,600
-22,724
| -3% | -$1.6M | 0.21% | 126 |
|
|
2018
Q1 | $61M | Sell |
809,324
-524,306
| -39% | -$41.7M | 0.24% | 108 |
|
|
2017
Q4 | $95.5M | Sell |
1,333,630
-1,465,253
| -52% | -$111M | 0.38% | 64 |
|
|
2017
Q3 | $227M | Sell |
2,798,883
-288,922
| -9% | -$22.1M | 0.98% | 7 |
|
|
2017
Q2 | $219M | Sell |
3,087,805
-564,456
| -15% | -$37.6M | 0.99% | 8 |
|
|
2017
Q1 | $248M | Sell |
3,652,261
-300,659
| -8% | -$21.1M | 1.12% | 3 |
|
|
2016
Q4 | $283M | Sell |
3,952,920
-65,871
| -2% | -$4.9M | 1.33% | 3 |
|
|
2016
Q3 | $318M | Buy |
4,018,791
+131,208
| +3% | +$10.7M | 1.4% | 4 |
|
|
2016
Q2 | $324M | Sell |
3,887,583
-281,656
| -7% | -$25M | 1.44% | 4 |
|
|
2016
Q1 | $383M | Sell |
4,169,239
-202,142
| -5% | -$18.2M | 1.72% | 2 |
|
|
2015
Q4 | $442M | Sell |
4,371,381
-173,452
| -4% | -$18M | 1.93% | 2 |
|
|
2015
Q3 | $446M | Buy |
4,544,833
+26,542
| +0.6% | +$2.95M | 1.83% | 4 |
|
|
2015
Q2 | $529M | Buy |
4,518,291
+106,833
| +2% | +$11.7M | 2.12% | 2 |
|
|
2015
Q1 | $433M | Buy |
4,411,458
+513,928
| +13% | +$52.2M | 1.78% | 2 |
|
|
2014
Q4 | $367M | Buy |
3,897,530
+212,919
| +6% | +$22M | 1.47% | 3 |
|
|
2014
Q3 | $392M | Sell |
3,684,611
-282,012
| -7% | -$27.6M | 1.68% | 2 |
|
|
2014
Q2 | $329M | Buy |
3,966,623
+1,463,021
| +58% | +$114M | 1.37% | 5 |
|
|
2014
Q1 | $177M | Buy |
2,503,602
+921,616
| +58% | +$72.3M | 0.77% | 21 |
|
|
2013
Q4 | $119M | Buy |
1,581,986
+1,702
| +0.1% | +$119K | 0.53% | 38 |
|
|
2013
Q3 | $99.3M | Buy |
1,580,284
+100,599
| +7% | +$6.01M | 0.49% | 48 |
|
|
2013
Q2 | $75.8M | Buy |
+1,479,685
| New | +$77.1M | 0.4% | 58 |
|
Other funds holding GILD
Axa's GILD Position: Q3 2025 in Review
Axa sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 1,602,225 shares — an estimated $178M sold.
Axa first reported a position in GILD in Q2 2013 and held it in 49 quarters. The position peaked at $529M in Q2 2015. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Axa reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Axa sold 1,602,225 Gilead Sciences shares in Q3 2025, an estimated $178M.
- Axa first reported a position in Gilead Sciences in Q2 2013 and held it in 49 quarters.
- Axa's Gilead Sciences position peaked at $529M in Q2 2015.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.